The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Guardant Health Inc’s stock clocked out at $67.47, up 5.11% from its previous closing price of $64.19. In other words, the price has increased by $5.11 from its previous closing price. On the day, 2.97 million shares were traded. GH stock price reached its highest trading level at $68.215 during the session, while it also had its lowest trading level at $64.58.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 17 ’25 when Tariq Musa sold 116 shares for $55.63 per share. The transaction valued at 6,453 led to the insider holds 7,591 shares of the business.
POTTER MYRTLE S sold 26 shares of GH for $1,446 on Sep 17 ’25. The Director now owns 18,281 shares after completing the transaction at $55.63 per share. On Sep 17 ’25, another insider, POTTER MYRTLE S, who serves as the Director of the company, bought 26 shares for $55.62 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GH now has a Market Capitalization of 8413904384 and an Enterprise Value of 9225248768. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.15. Its current Enterprise Value per Revenue stands at 11.13 whereas that against EBITDA is -22.011.
Stock Price History:
The Beta on a monthly basis for GH is 1.53, which has changed by 2.1039653 over the last 52 weeks, in comparison to a change of 0.13033986 over the same period for the S&P500. Over the past 52 weeks, GH has reached a high of $68.00, while it has fallen to a 52-week low of $20.14. The 50-Day Moving Average of the stock is 11.53%, while the 200-Day Moving Average is calculated to be 39.62%.
Shares Statistics:
It appears that GH traded 2.56M shares on average per day over the past three months and 1743950 shares per day over the past ten days. A total of 124.48M shares are outstanding, with a floating share count of 119.11M. Insiders hold about 4.48% of the company’s shares, while institutions hold 100.10% stake in the company. Shares short for GH as of 1759190400 were 8265188 with a Short Ratio of 3.23, compared to 1756425600 on 8024125. Therefore, it implies a Short% of Shares Outstanding of 8265188 and a Short% of Float of 6.959999999999999.
Earnings Estimates
As of right now, 13.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.48, with high estimates of -$0.4 and low estimates of -$0.55.
Analysts are recommending an EPS of between -$1.74 and -$1.97 for the fiscal current year, implying an average EPS of -$1.88. EPS for the following year is -$1.65, with 16.0 analysts recommending between -$1.23 and -$2.21.
Revenue Estimates
In. The current quarter, 20 analysts expect revenue to total $235.69M. It ranges from a high estimate of $240M to a low estimate of $231.6M. As of. The current estimate, Guardant Health Inc’s year-ago sales were $191.48MFor the next quarter, 20 analysts are estimating revenue of $250.51M. There is a high estimate of $254.4M for the next quarter, whereas the lowest estimate is $247.4M.
A total of 22 analysts have provided revenue estimates for GH’s current fiscal year. The highest revenue estimate was $928.52M, while the lowest revenue estimate was $915.8M, resulting in an average revenue estimate of $922.04M. In the same quarter a year ago, actual revenue was $739.02MBased on 22 analysts’ estimates, the company’s revenue will be $1.15B in the next fiscal year. The high estimate is $1.23B and the low estimate is $1.08B.
